Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development.
Sign Up to like & getrecommendations! Published in 2017 at "European journal of endocrinology"
DOI: 10.1530/eje-17-0151
Abstract: CONTEXT Growth hormone (GH) stimulates hepatic synthesis of very-low-density lipoproteins (VLDL), whereas hepatic steatosis develops as a result of GH deficiency. Steatosis is also a complication of tamoxifen treatment, the cause of which is not… read more here.
Keywords: secretion; hepatic vldl; vldl; vldl apob ... See more keywords
Physiological interindividual variability in endogenous estradiol concentration does not influence adipose tissue and hepatic lipid kinetics in women.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-22-0410
Abstract: Objective Increased triglyceride (TG) and apolipoprotein B-100 (apoB-100) concentrations in plasma are important risk factors for cardiovascular disease in women. Administration of some estrogen preparations raises plasma TG and apoB-100 concentrations by increasing hepatic very… read more here.
Keywords: vldl vldl; vldl apob; vldl; estradiol concentration ... See more keywords
Cholesterol Content of Very-Low-Density Lipoproteins Is Associated with 1-Year Mortality in Acute Heart Failure Patients
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12101542
Abstract: Considering the relationship between the extent of metabolic derangement and the disease severity in heart failure, we hypothesized that the lipid content of very-low-density lipoprotein (VLDL) may have prognostic value for 1 year mortality in… read more here.
Keywords: year; vldl vldl; vldl apob; vldl ... See more keywords